Drugs for erectile dysfunction inhibit an enzyme that, according to lab research, may increase the risk of malignant melanoma. Human research has been limited. This week in his Analysis in 150 Seconds, Perry Wilson, MD, looks at the evidence.
F. Perry Wilson, MD, is an assistant professor of medicine at the Yale School of Medicine. He earned his BA from Harvard University, graduating with honors with a degree in biochemistry. He then attended Columbia College of Physicians and Surgeons in New York City. From there he moved to Philadelphia to complete his internal medicine residency and nephrology fellowship at the Hospital of the University of Pennsylvania. During his research time, Dr. Wilson also obtained a Master of Science in Clinical Epidemiology from the University of Pennsylvania. He is an accomplished author of many scientific articles and holds several NIH grants. He is a ڴŮ reviewer, and in addition to his video analyses he authors a blog, . You can follow .